Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Solvay agrees to acquire Fournier

Executive Summary

To strengthen its cardiology business and research pipeline, Solvay has signed a memorandum of understanding to buy Fournier Pharma for €1.3bn ($2.1bn) in cash. Both have portfolios of drugs to treat cardiovascular, gastroenterological, psychiatric, and gynecological conditions.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Preliminary
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Full Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register